Spots Global Cancer Trial Database for Immune Profiling for Cancer Immunotherapy Response
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immune Profiling for Cancer Immunotherapy Response
Official Title: Immune Profiling for Cancer Immunotherapy Response
Study ID: NCT06116032
Interventions
Study Description
Brief Summary: In patients clinically treated with FDA-approved immunotherapy the investigators will assess the predictive value of pre- and on-treatment 1) immune-methylation profiling across cancer types, and 2) immune-methylation profiling and cytokine profiling within cancer types.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Contact Details
Name: Brock C Christensen, PhD
Affiliation: Dartmouth College
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
